Ali I. Fattom
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.7MFederal grants as PI4 awards
1Patents grantedLatest Oct 19, 2021
87Papers3,906 citations
Federal awards and patents by year
AwardsPatents
4 awards · $2.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 3, 2020 | NIH | SBIR Phase II Pre-Clinical Development of a Intranasal Bivalent gD2/gB2 HSV-2 Mucosal Vaccine | $999K | BLUEWILLOW BIOLOGICS INC |
| Apr 4, 2018 | NIH | SBIR Phase I Development of a nanoemulsion-based vaccine for chlamydia infection | $216K | BLUEWILLOW BIOLOGICS INC |
| Feb 26, 2018 | NIH | SBIR Phase II Development of a nanoemulsion-adjuvanted prophylactic HSV-2 vaccine | $695K | BLUEWILLOW BIOLOGICS INC |
| Feb 23, 2017 | NIH | SBIR Phase II Development of a nanoemulsion-adjuvanted prophylactic HSV-2 vaccine | $798K | BLUEWILLOW BIOLOGICS INC |
2 patents as inventor
- US 11147869BLUEWILLOW BIOLOGICS INCOct 19, 2021
- US BLUEWILLOW BIOLOGICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#703
Awards as PI#566
Patents#155
Companies
- BLUEWILLOW BIOLOGICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.